美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tevogen Bio Holdings

1.01

+0.03163.23%

盤後：0.9920-0.0180-1.78%19:59 EDT

成交量：77.23萬

成交額：77.82萬

市值：1.86億

市盈率：-14.42

高：1.03

開：0.9895

低：0.9700

收：0.9784

資料載入中...

總覽公司新聞公告

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌5.17%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.43%

Tevogen Bio Holdings Inc.盤中異動大幅跳水6.58%報1.26美元

Tevogen Bio Holdings Inc.盤中異動大幅跳水5.71%報0.990美元

Tevogen Bio Holdings Inc.盤中異動早盤快速下挫5.14%報1.02美元

Tevogen Bio Holdings Inc.盤中異動下午盤股價大漲5.92%

Tevogen Bio Holdings Inc.盤中異動急速下跌5.88%報0.960美元

Tevogen Bio Holdings Inc.盤中異動大幅拉昇5.06%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.14%報1.02美元

Tevogen Bio Holdings Inc.盤中異動股價大跌5.31%報1.07美元

Tevogen Bio Holdings Inc.盤中異動早盤快速下挫5.05%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.85%

Tevogen Bio Holdings Inc.盤中異動大幅下挫5.34%

Tevogen Bio Holdings Inc.盤中異動大幅下挫5.04%報1.30美元

Tevogen Bio Holdings Inc.盤中異動股價大漲7.04%

Tevogen Bio Holdings Inc.盤中異動快速下挫5.33%報1.42美元

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌7.01%

Tevogen Bio Holdings Inc.股價上漲21.76% 市值漲6149.18萬美元

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌5.21%

Tevogen Bio Holdings Inc.盤中異動急速跳水5.55%報1.70美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TVGN/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.01,"timestamp":1746216000000,"preClose":0.9784,"halted":0,"volume":772284,"hourTrading":{"tag":"盘后","latestPrice":0.992,"preClose":1.01,"latestTime":"19:59 EDT","volume":29907,"amount":29866.2064,"timestamp":1746230399310},"delay":0,"floatShares":22757419,"shares":183893433,"eps":-0.070045,"marketStatus":"休市中","change":0.0316,"latestTime":"05-02 16:00:00 EDT","open":0.9895,"high":1.03,"low":0.97,"amount":778181.0061672,"amplitude":0.061325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.070045,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9784,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":0.9784,"latestTime":"09:23 EDT","volume":8404,"amount":8138.594956800001,"timestamp":1746192222253},"postHourTrading":{"tag":"盘后","latestPrice":0.992,"preClose":1.01,"latestTime":"19:59 EDT","volume":29907,"amount":29866.2064,"timestamp":1746230399310},"volumeRatio":0.16018872693681308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":22757419,"roa":"-746.67%","roe":"--","lyrEps":-0.070045,"volumeRatio":0.16018872693681308,"shares":183893433,"dividePrice":0,"high":1.03,"amplitude":0.061325,"preClose":0.9784,"low":0.97,"week52Low":0.2556,"pbRate":"-12.00","week52High":3.09,"institutionHeld":0,"latestPrice":1.01,"eps":-0.070045,"divideRate":0,"volume":772284,"delay":0,"ttmEps":-0.070045,"open":0.9895,"prevYearClose":1.03,"prevWeekClose":0.9922,"prevMonthClose":1.03,"prevQuarterClose":1.08,"fiveDayClose":0.9922,"twentyDayClose":1,"sixtyDayClose":1.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503474586","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503474586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503474586?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 22:31","pubTimestamp":1736778708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下跌5.17%。截至发稿，该股报1.38美元/股，成交量7.8445万股，换手率0.04%，振幅1.38%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223148960252cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223148960252cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2502893471","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502893471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502893471?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 23:06","pubTimestamp":1736521614,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时06分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下跌5.43%。截至发稿，该股报1.22美元/股，成交量36.282万股，换手率0.21%，振幅3.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230655aba60bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230655aba60bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2501899097","title":"Tevogen Bio Holdings Inc.盤中異動 大幅跳水6.58%報1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501899097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501899097?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 22:36","pubTimestamp":1736260591,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时36分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水6.58%。截至发稿，该股报1.26美元/股，成交量23.6037万股，换手率0.13%，振幅3.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223632aba1e05f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223632aba1e05f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2495145386","title":"Tevogen Bio Holdings Inc.盤中異動 大幅跳水5.71%報0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495145386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495145386?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 23:08","pubTimestamp":1735657718,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时08分，Tevogen Bio Holdings Inc.股票出现波动，股价急速跳水5.71%。截至发稿，该股报0.990美元/股，成交量50.3321万股，换手率0.29%，振幅8.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231230838ab998972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231230838ab998972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2494437862","title":"Tevogen Bio Holdings Inc.盤中異動 早盤快速下挫5.14%報1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494437862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494437862?lang=zh_tw&edition=fundamental","pubTime":"2024-12-26 23:47","pubTimestamp":1735228071,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时47分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报1.02美元/股，成交量88.6674万股，换手率0.51%，振幅8.41%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226234751a20aa5cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226234751a20aa5cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2493799050","title":"Tevogen Bio Holdings Inc.盤中異動 下午盤股價大漲5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493799050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493799050?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 02:32","pubTimestamp":1734978720,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日02时32分，Tevogen Bio Holdings Inc.股票出现异动，股价急速上涨5.92%。截至发稿，该股报1.055美元/股，成交量61.9275万股，换手率0.35%，振幅7.93%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224023201984d3e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224023201984d3e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2492918793","title":"Tevogen Bio Holdings Inc.盤中異動 急速下跌5.88%報0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918793?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 05:01","pubTimestamp":1734469274,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日05时01分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.88%。截至发稿，该股报0.960美元/股，成交量116.481万股，换手率0.67%，振幅6.86%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218050114984c94b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218050114984c94b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2490286286","title":"Tevogen Bio Holdings Inc.盤中異動 大幅拉昇5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490286286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490286286?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 00:05","pubTimestamp":1733933143,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时05分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.06%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000543ab6ff947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000543ab6ff947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2490043805","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.14%報1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490043805?lang=zh_tw&edition=fundamental","pubTime":"2024-12-10 23:12","pubTimestamp":1733843567,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时12分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下挫5.14%。截至发稿，该股报1.02美元/股，成交量19.1463万股，换手率0.11%，振幅4.49%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.49%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231247984b0e2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231247984b0e2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2489450908","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.31%報1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489450908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489450908?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 22:59","pubTimestamp":1733410740,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时59分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下跌5.31%。截至发稿，该股报1.07美元/股，成交量24.8334万股，换手率0.14%，振幅4.43%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225900a1d6a894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225900a1d6a894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2488190436","title":"Tevogen Bio Holdings Inc.盤中異動 早盤快速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488190436?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 23:01","pubTimestamp":1733324466,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时01分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫5.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423010798e55e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423010798e55e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2488294612","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488294612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488294612?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 22:35","pubTimestamp":1733236513,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时35分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.85%。截至发稿，该股报1.11美元/股，成交量10.6683万股，换手率0.06%，振幅2.51%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223513a26997b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223513a26997b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2488677535","title":"Tevogen Bio Holdings Inc.盤中異動 大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488677535?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 22:39","pubTimestamp":1733150357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时39分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.34%。截至发稿，该股报1.24美元/股，成交量19.3374万股，换手率0.11%，振幅3.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222391898e4ebbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222391898e4ebbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2487656115","title":"Tevogen Bio Holdings Inc.盤中異動 大幅下挫5.04%報1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487656115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487656115?lang=zh_tw&edition=fundamental","pubTime":"2024-11-30 00:16","pubTimestamp":1732896980,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时16分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报1.30美元/股，成交量78.2406万股，换手率0.45%，振幅6.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130001620971aab0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130001620971aab0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2486001268","title":"Tevogen Bio Holdings Inc.盤中異動 股價大漲7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486001268?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 22:46","pubTimestamp":1732632392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时46分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅拉升7.04%。截至发稿，该股报1.52美元/股，成交量48.5655万股，换手率0.28%，振幅8.39%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622463398e44ad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622463398e44ad8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2486425038","title":"Tevogen Bio Holdings Inc.盤中異動 快速下挫5.33%報1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486425038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486425038?lang=zh_tw&edition=fundamental","pubTime":"2024-11-25 22:35","pubTimestamp":1732545321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌5.33%。截至发稿，该股报1.42美元/股，成交量33.5565万股，换手率0.19%，振幅4.73%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223521abddfc26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223521abddfc26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2485303269","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485303269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485303269?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 22:30","pubTimestamp":1732285851,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时30分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫7.01%。截至发稿，该股报1.53美元/股，成交量16.9181万股，换手率0.10%，振幅1.52%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2484954110","title":"Tevogen Bio Holdings Inc.股價上漲21.76% 市值漲6149.18萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484954110?lang=zh_tw&edition=fundamental","pubTime":"2024-11-20 22:31","pubTimestamp":1732113077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升21.76%。截至发稿，该股报1.66美元/股，成交量1016.98万股，换手率5.96%，振幅1.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2484679388","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484679388?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 22:41","pubTimestamp":1731940870,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时41分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.21%。截至发稿，该股报1.38美元/股，成交量16.9023万股，换手率0.10%，振幅4.11%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2483208804","title":"Tevogen Bio Holdings Inc.盤中異動 急速跳水5.55%報1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483208804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483208804?lang=zh_tw&edition=fundamental","pubTime":"2024-11-14 22:48","pubTimestamp":1731595681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下挫5.55%。截至发稿，该股报1.70美元/股，成交量23.611万股，换手率0.14%，振幅7.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2025-05-02","current":-13.10675,"percent":0.681004,"low":-87.683882,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"high":-2.106753,"avg":-22.867361,"sd":16.134682,"marketCap":179921334},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334}],"updateTime":1746323036670}}}